10-(3-Bromophenyl)-14,14-dimethyl-2,9-diazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6-tetraen-12-one

Catalog No. :
ACZUYF132
CAS No. :
149774-60-7
Molecular Formula :
C21H21BrN2O
Molecular Weight :
397.32

IUPAC Name:11-(3-bromophenyl)-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one

10-(3-Bromophenyl)-14,14-dimethyl-2,9-diazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6-tetraen-12-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$282.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name10-(3-Bromophenyl)-14,14-dimethyl-2,9-diazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6-tetraen-12-one
IUPAC Name11-(3-bromophenyl)-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one
Molecular FormulaC21H21BrN2O
Molecular Weight397.32
SMILESO=C1CC(C)(C)CC2=C1C(C3=CC=CC(Br)=C3)NC4=CC=CC=C4N2
InChI KeyWOAGWKCGXQPAPI-UHFFFAOYSA-N
Synonym11-(3-bromophenyl)-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one;1H-Dibenzo[b,e][1,4]diazepin-1-one, 11-(3-bromophenyl)-2,3,4,5,10,11-hexahydro-3,3-dimethyl-
CAS No.149774-60-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZUYF132 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZUYF132 route product structure diagram
    ACZUYF132149774-60-7
Inquiry

2. ACZUYF132 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZUYF132 route product structure diagram
    ACZUYF132149774-60-7
Inquiry

Comments (0)